Skip to content

Clinical trials

Phase 3 Neuralgia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 3 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20071
20101
20113
20122
20161
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
BioDelivery Sciences International2
Advanced Magnetic Research Institute International1
Cephalon1
Columbia University1
Eastern Virginia Medical School1
Indiana University1
Kathleen Friel1
NeurogesX1
New Mexico Cancer Research Alliance1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia15
Pain6
Diabetic Neuropathies4
Low Back Pain3
Osteoarthritis3
Spinal Cord Injuries3
Peripheral Nervous System Diseases2
Acute Pain1
Back Pain1
Chronic Pain1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.